Horizontal rectus surgery is successful for Duane syndrome

Article

Performing moderate horizontal rectus surgery in Duane syndrome patients is a simple and effective procedure.

Performing moderate horizontal rectus surgery in Duane syndrome patients is a simple and effective procedure, according to a study in the European Journal of Ophthalmology.

A team headed by Dr Pilar Merino, Department of Ophthalmology, Hospital Gregorio Marañón, Madrid, Spain, included 17 Duane syndrome patients who experienced strabismus surgery between 2000 and 2008.

All patients either had medial rectus recession for esotropic deviation or lateral rectus recession for exotropic deviation. The amount of surgery depended on the angle of deviation and abnormal head posture. A good angle of deviation was defined as less than 10 PD and 5º after surgery was considered a good head turn. Head turn was determined as mild, moderate or severe.

In 12 patients the treatment was successful and in the remaining five cases treatment was unsuccessful. Three patients experienced an under corrected deviation and two patients experienced an overcorrected deviation.

The surgery was considered an overall success and there were no secondary duction limitations. In 33% of the patients the surgery only slightly improved abduction.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.